AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC).
Eric Pujade-Lauraine
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Felix Hilpert
Consultant or Advisory Role - Roche
Honoraria - Roche
Other Remuneration - Roche
BĂ©atrice Weber
No relevant relationships to disclose
Alexander Reuss
No relevant relationships to disclose
Andres Poveda
Consultant or Advisory Role - Roche
Gunnar Kristensen
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Roberto Sorio
No relevant relationships to disclose
Ignace B. Vergote
Consultant or Advisory Role - Roche
Petronella Witteveen
No relevant relationships to disclose
Aristotelis Bamias
Consultant or Advisory Role - Roche
Research Funding - Roche
Deolinda Pereira
Honoraria - Janssen-Cilag; Roche
Pauline Wimberger
Honoraria - Roche
Ana Oaknin
No relevant relationships to disclose
Mansoor Raza Mirza
Consultant or Advisory Role - Roche
Honoraria - Roche
Philippe Follana
No relevant relationships to disclose
David T. Bollag
Employment or Leadership Position - Roche
Stock Ownership - Roche
Isabelle Ray-Coquard
Honoraria - Amgen; Merck; Novartis; PharmaMar; Roche; Sanofi
Research Funding - Merck; Novartis; Roche